108 related articles for article (PubMed ID: 1079571)
21. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
[TBL] [Abstract][Full Text] [Related]
22. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
Sauer H; Wilmanns W
Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
24. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
Sirotnak FM; Moccio DM; Dorick DM
Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
[TBL] [Abstract][Full Text] [Related]
25. Patient case involving high-dose methotrexate followed by leucovorin rescue.
Alsop JA
Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
[No Abstract] [Full Text] [Related]
26. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
Levi M; Sulkes A; Katz E; Rizel S; Biran S
Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
[No Abstract] [Full Text] [Related]
27. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
Paparopoli G; Agostara B; Di Girolamo G
Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
[No Abstract] [Full Text] [Related]
28. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
[TBL] [Abstract][Full Text] [Related]
29. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
[No Abstract] [Full Text] [Related]
30. Letter: Limitations of methotrexate and citrovorum-factor treatment.
Frei E; Jaffe NJ; Pitman S
N Engl J Med; 1975 Jan; 292(2):107-8. PubMed ID: 1078551
[No Abstract] [Full Text] [Related]
31. Improved therapeutic index of methotrexate with "leucovorin rescue".
Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
[No Abstract] [Full Text] [Related]
32. [Weekly high-dose methotrexate with citrovorum factor rescue for non-Hodgkin's lymphoma--serum methotrexate level and safety administration (author's transl)].
Sasaki K; Fujimoto T; Goya N
Rinsho Ketsueki; 1979 Jan; 20(1):90-7. PubMed ID: 311390
[No Abstract] [Full Text] [Related]
33. Failure of moderate-dose prolonged-infusion methotrexate and citrovorum factor rescue in patients with previously treated metastatic neuroblastoma--a phase II study.
Ablin AR; Bleyer WA; Finklestein JZ; Hartmann JR; Leikin S; Hammond GD
Cancer Treat Rep; 1978 Jul; 62(7):1097-9. PubMed ID: 356972
[No Abstract] [Full Text] [Related]
34. Methotrexate. II. Use in pediatric chemotherapy.
Lippens RJ
Am J Pediatr Hematol Oncol; 1984; 6(4):397-413. PubMed ID: 6398630
[TBL] [Abstract][Full Text] [Related]
35. [Effect of methotrexate-citrovorum factor (MTX-CF) rescue therapy in a case of malignant histiocytosis with disseminated intravascular coagulation (author's transl)].
Fukuhara S; Kim R; Aoki Y; Okada S; Yoneda M; Kita K; Nasu K; Tatsumi E; Shirakawa S; Uchino H
Rinsho Ketsueki; 1981 Jul; 22(7):1145-51. PubMed ID: 6977047
[No Abstract] [Full Text] [Related]
36. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies].
Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592
[No Abstract] [Full Text] [Related]
37. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
Von Hoff DD; Penta JS; Helman LJ; Slavik M
Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
[TBL] [Abstract][Full Text] [Related]
38. Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues.
Straw JA; Talbot DC; Taylor GA; Harrap KR
J Natl Cancer Inst; 1977 Jan; 58(1):91-7. PubMed ID: 299894
[TBL] [Abstract][Full Text] [Related]
39. High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
Case DC
J Maine Med Assoc; 1980 Dec; 71(12):355-8. PubMed ID: 6970790
[No Abstract] [Full Text] [Related]
40. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
